title: Biochemical evidence of atherosclerosis progression mediated by increased oxidative stress in apolipoprotein E-deficient spontaneously hyperlipidemic mice exposed to chronic cigarette smoke.
abstract: Cigarette smoking is a major risk factor for cardiovascular disease. The induction of oxidative stress by smoking plays a key role in the progression of atherosclerosis. However, the underlying mechanisms are not fully understood. In the present study, we investigated whether long-term smoking can accelerate the progression of atherosclerosis and whether oxidative stress is implicated in its pathogenesis. Apolipoprotein E-deficient spontaneously hyperlipidemic mice, a model of atherosclerosis, were exposed to the gas-phase of smoke, from which tar and nicotine had been removed, for 15 min a day, 6 days a week, for 16 weeks. Exposure to cigarette smoke significantly increased the serum levels of oxidative stress markers such as thiobarbituric acid-reactive substances, oxidatively modified low-density lipoproteins, and 3-nitrotyrosine, but it did not affect serum cholesterol and triglyceride levels. Exposure to smoke also accelerated the accumulation of total cholesterol levels in the aorta that was accompanied by an increase in 3-nitrotyrosine levels of the atherosclerotic mice. These changes in the serum and aorta that progressed with exposure to smoke were prevented by vitamin E administration. Our data suggest that chronic cigarette smoking promotes and aggravates atherosclerosis and that the antioxidant vitamin E exerts an anti-atherogenic effect via reduction of oxidative stress.
authors: School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Japan. masaru@mukogawa-u.ac.jp
authors: Masaru
authors: M
authors: Kunitomo
authors: Yu
authors: Y
authors: Yamaguchi
authors: Satomi
authors: S
authors: Kagota
authors: Noriko
authors: N
authors: Yoshikawa
authors: Kazuki
authors: K
authors: Nakamura
authors: Kazumasa
authors: K
authors: Shinozuka
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001057:Apolipoproteins E / Q000172:deficiency*; D050197:Atherosclerosis / Q000209:etiology*; D004195:Disease Models, Animal; D018450:Disease Progression; D006949:Hyperlipidemias; D008297:Male; D051379:Mice; D018384:Oxidative Stress / Q000187:drug effects*; D012906:Smoke; D014026:Nicotiana / Q000009:adverse effects*; D014028:Tobacco Smoke Pollution / Q000009:adverse effects; D014810:Vitamin E / Q000494:pharmacology*
chemical_list: D000975:Antioxidants; D001057:Apolipoproteins E; D012906:Smoke; D014028:Tobacco Smoke Pollution; D014810:Vitamin E